• Latest Posts

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

Sponsored by 24 Oct 2023

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

In Depth 15 Aug 2023

Can stem cell treatment repair damaged knees?

Five recent advancements in arthritis research over the past year

10 immunotherapy companies making waves in 2023


Biogen acquiring Reata Pharmaceuticals for $7.3B

Podcast 20 Jul 2023

Beyond Biotech podcast 55: Inflammasomes

Immune memory research could lead to next generation of epigenetic drugs

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

NodThera announces positive inflammatory disease data

Diagnosing inflammatory diseases with synthetic peptides